Table 4.
AUCs of Marker-Panels for the Tetra-Antennary Glycoforms Markers and Variablesa
| all HCC vs cirrhosis |
early HCC vs cirrhosis |
MASLD All HCC vs Cirrhosis |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| marker panel | AUC (95%CI) | Sens80 | p-value | AUC (95%CI) | Sens80 | p-value | AUC (95%CI) | Sens80 | p-value |
| AFP | 0.756(0.667–0.837) | 0.586 | reference | 0.74(0.631–0.84) | 0.557 | reference | 0.850(0.716–0.958) | 0.817 | reference |
| marker-combination | 0.702(0.607–0.79) | 0.424 | 0.3999 | 0.702(0.597–0.801) | 0.387 | 0.6218 | 0.609(0.432–0.775) | 0.348 | 0.0237 |
| AFP + Age + Gender2+Marker-combination | 0.871(0.8–0.931) | 0.763 | 0.0336 | 0.887(0.815–0.942) | 0.703 | 0.0190 | 0.901(0.785–0.981) | 0.739 | 0.5228 |
| AFP + Gender2+ marker-combination | 0.834(0.754–0.903) | 0.644 | 0.1676 | 0.825(0.738–0.898) | 0.649 | 0.2100 | 0.891(0.77–0.983) | 0.739 | 0.6200 |
Marker-combination: A4G4F3S2+A4G4F1S3+A4G4F3S3+A4G4F2S4; Sens80: the sensitivity when specificity was fixed at 80%; P-values of marker panels were obtained by comparing the ROC curves of the marker panels to that of AFP alone (reference).